Quality in stroke care during the early phases of the COVID-19 pandemic:A nationwide study

Autor: Rolf A Blauenfeldt, Jakob N Hedegaard, Christina Kruuse, David Gaist, Troels Wienecke, Boris Modrau, Dorte Damgaard, Søren P Johnsen, Grethe Andersen, Claus Z Simonsen

Publikováno v: Blauenfeldt, R A, Hedegaard, J N, Kruuse, C, Gaist, D, Wienecke, T, Modrau, B, Damgaard, D, Johnsen, S P, Andersen, G & Simonsen, C Z 2023, ' Quality in stroke care during the early phases of the COVID-19 pandemic : A nationwide study ', European Stroke Journal, vol. 8, no. 1, pp. 268-274 . https://doi.org/10.1177/23969873221139695

Introduction: Evidence-based early stroke care as reflected by fulfillment of process performance measures, is strongly related to better patient outcomes after stroke and transient ischemic attack (TIA). Detailed data on the resilience of stroke car

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae6b90dd1de03b3c03661e616ca8517a
https://vbn.aau.dk/da/publications/cb729d15-de91-428e-a04b-b9aa172f4757

Is the socioeconomic inequality in stroke prognosis changing over time and does quality of care play a role?

Autor: Vibe Bolvig Hyldgård, Rikke Søgaard, Jan Brink Valentin, Theis Lange, Dorte Damgaard, Søren Paaske Johnsen

Publikováno v: Hyldgård, V B, Søgaard, R, Valentin, J B, Lange, T, Damgaard, D & Johnsen, S P 2022, ' Is the socioeconomic inequality in stroke prognosis changing over time and does quality of care play a role? ', European Stroke Journal . https://doi.org/10.1177/23969873221146591
Eur Stroke J

Introduction: In a publicly financed healthcare system we aimed to study the development in socioeconomic disparity in ischemic stroke outcomes over time. In addition, we study whether the healthcare system affects these outcomes through the quality

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a79995801d882acbf390b21a09c7eee
https://vbn.aau.dk/da/publications/f2cff74e-c779-4fc6-875c-25c28614c65a

Rivaroxaban versus aspirin for prevention of covert brain infarcts in patients with embolic stroke of undetermined source:NAVIGATE ESUS MRI substudy

Autor: Josep Puig, Nikolay Shamalov, Kanjana S Perera, Feryal Saad, Dániel Bereczki, Jochen B. Fiebach, Hardi Mundl, Martin J O’Donnell, Danilo Toni, Sebastián F. Ameriso, Dorte Damgaard, Roland Veltkamp, Stefan T. Engelter, Lesly A. Pearce, Byung-Woo Yoon, Keith W. Muir, Robert Mikulik, Eric E. Smith, Scott D. Berkowitz, Scott E. Kasner, Rubens José Gagliardi, Ashkan Shoamanesh, Robert G. Hart, Mukul Sharma

Publikováno v: Sharma, M, Smith, E E, Pearce, L A, Perera, K S, Kasner, S E, Yoon, B W, Ameriso, S F, Puig, J, Damgaard, D, Fiebach, J B, Muir, K W, Veltkamp, R C, Toni, D S, Shamalov, N, Gagliardi, R J, Mikulik, R, Engelter, S T, Bereczki, D, O’Donnell, M J, Saad, F, Shoamanesh, A, Berkowitz, S D, Mundl, H, Hart, R G & On behalf of the NAVIGATE ESUS MRI Substudy Investigators 2022, ' Rivaroxaban versus aspirin for prevention of covert brain infarcts in patients with embolic stroke of undetermined source : NAVIGATE ESUS MRI substudy ', International Journal of Stroke, vol. 17, no. 7, pp. 799-805 . https://doi.org/10.1177/17474930211058012

Background Covert brain infarcts are associated with important neurological morbidity. Their incidence in patients with embolic stroke of undetermined source (ESUS) is unknown. Aims To assess the incidence of covert brain infarcts and cerebral microb

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f55e65432bf70532f0f32f8ab28c82aa
https://pure.au.dk/portal/da/publications/rivaroxaban-versus-aspirin-for-prevention-of-covert-brain-infarcts-in-patients-with-embolic-stroke-of-undetermined-source(4eabcadd-5683-4af5-b418-fc60e9212ac1).html

Specialized Outpatient Clinic vs Stroke Unit for TIA and Minor Stroke

Autor: M S Poulsen, Helle K. Iversen, Sidsel Hastrup, Claus Z Simonsen, Martin Bach Jensen, Grethe Andersen, Dorte Damgaard, Thomas Harbo, Søren Paaske Johnsen, Niels Hjort, Anette Torvin Møller, P von Weitzel-Mudersbach

Publikováno v: Hastrup, S, Johnsen, S P, Jensen, M, von Weitzel-Mudersbach, P, Simonsen, C Z, Hjort, N, Møller, A T, Harbo, T, Poulsen, M S, Iversen, H K, Damgaard, D & Andersen, G 2021, ' Specialized Outpatient Clinic vs Stroke Unit for TIA and Minor Stroke : A Cohort Study ', Neurology, vol. 96, no. 8, pp. e1096-e1109 . https://doi.org/10.1212/WNL.0000000000011453
Neurology
article-version (Version of Record) 3
Hastrup, S, Johnsen, S P, Jensen, M, von Weitzel-Mudersbach, P, Simonsen, C Z, Hjort, N, Moller, A T, Harbo, T, Poulsen, M S, Iversen, H K, Damgaard, D & Andersen, G 2021, ' Specialized Outpatient Clinic vs Stroke Unit for TIA and Minor Stroke A Cohort Study ', Neurology, vol. 96, no. 8, pp. E1096-E1109 . https://doi.org/10.1212/WNL.0000000000011453

ObjectiveTo evaluate the effects of an outpatient clinic setup for minor stroke/TIA using subsequent admission of patients at high risk of recurrent stroke.MethodsWe performed a cohort study of all patients with suspected minor stroke/TIA seen in an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab8cc0e483d1cc5d4bba98ada5d2f538
https://doi.org/10.1212/wnl.0000000000011453

Left atrial appendage occlusion vs novel oral anticoagulation for stroke prevention in atrial fibrillation:Rationale and Design of the Multicenter Randomized Occlusion-AF Trial

Autor: Jens Erik Nielsen-Kudsk, Halvor Naess, Kristina Laut Matzen, Jukka Putaala, Mohammad Ahmad Al-Jazi, Erik J S Packer, Jan Brink Valentin, Jan-Erik Karlsson, Søren Paaske Johnsen, Jacob Odenstedt, Jacob Pontoppidan, Boris Modrau, Kasper Korsholm, Jakob Hjort, Dorte Damgaard, Juha Sinisalo

Publikováno v: Korsholm, K, Damgaard, D, Valentin, J B, Packer, E J S, Odenstedt, J, Sinisalo, J, Putaala, J, Næss, H, Al-Jazi, M A, Karsson, J-E, Pontoppidan, J, Modrau, B, Hjort, J, Matzen, K L, Johnsen, S P & Nielsen-Kudsk, J E 2022, ' Left atrial appendage occlusion vs novel oral anticoagulation for stroke prevention in atrial fibrillation : Rationale and Design of the Multicenter Randomized Occlusion-AF Trial ', American Heart Journal, vol. 243, pp. 28-38 . https://doi.org/10.1016/j.ahj.2021.08.020
Korsholm, K, Damgaard, D, Valentin, J B, Packer, E J S, Odenstedt, J, Sinisalo, J, Putaala, J, Næss, H, Al-Jazi, M A, Karsson, J-E, Pontoppidan, J, Modrau, B, Hjort, J, Matzen, K L, Johnsen, S P & Nielsen-Kudsk, J E 2022, ' Left atrial appendage occlusion vs novel oral anticoagulation for stroke prevention in atrial fibrillation : Rationale and design of the multicenter randomized occlusion-AF trial ', American Heart Journal, vol. 243, pp. 28-38 . https://doi.org/10.1016/j.ahj.2021.08.020
Korsholm, K, Damgaard, D, Valentin, J B, Packer, E J S, Odenstedt, J, Sinisalo, J, Putaala, J, Næss, H, Al-Jazi, M A, Karlsson, J E, Pontoppidan, J, Modrau, B, Hjort, J, Matzen, K L, Johnsen, S P & Nielsen-Kudsk, J E 2022, ' Left atrial appendage occlusion vs novel oral anticoagulation for stroke prevention in atrial fibrillation : rationale and design of the multicenter randomized occlusion-AF trial ', American Heart Journal, vol. 243, pp. 28-38 . https://doi.org/10.1016/j.ahj.2021.08.020

Background: The prevalence of atrial fibrillation (AF) is increasing globally, which is a major clinical and public health concern due to the 5-fold increased risk of stroke. Oral anticoagulation with novel oral anticoagulants (NOACs) is the current

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0924ec04b22955349e1f7c3f41b042f8
https://vbn.aau.dk/da/publications/31655018-c285-4035-b7af-4fcfc12e79f8